A U.K. analysis of more than 400,000 people who received both doses of Pfizer's COVID-19 vaccine showed the shot's efficacy waned slightly after five to six months, CNBC reported Aug. 25.
The shot was 88 percent effective at preventing COVID-19 infection one month after the second dose and 74 percent effective five to six months after the second dose.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,